Spear Bio at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Spear Bio takes part in 3 sessions at CTAD 2026 in Boston. Its program centres on its SPEAR immunoassays, including a five-marker panel for tau, neurofilament and GFAP. Its work also covers synuclein assays to improve Parkinson's disease stratification.

OrganizationCTAD 2026 Attendance
Spear Bio
Woburn, Massachusetts
◇Silver Sponsor
spear.bio
Biomarker & diagnostics companiesSilver Sponsor
Makes SPEAR ultrasensitive immunoassays, including blood p-tau217 tests and multiplex tau, NfL and GFAP panels for Alzheimer's research.
Poster
Wed Nov 18
7:15am–5:30pm
Poster
Wed Nov 18
7:15am–5:30pm
Poster
Wed Nov 18
7:15am–5:30pm

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Spear Bio

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction